Cargando…

The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis

Rationale: Chronic hypersensitivity pneumonitis (CHP) is a condition that arises after repeated exposure and sensitization to inhaled antigens. The lung microbiome is increasingly implicated in respiratory disease, but, to date, no study has investigated the composition of microbial communities in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Invernizzi, Rachele, Wu, Benjamin G., Barnett, Joseph, Ghai, Poonam, Kingston, Shaun, Hewitt, Richard J., Feary, Johanna, Li, Yonghua, Chua, Felix, Wu, Zhe, Wells, Athol U., George, Peter M., Renzoni, Elisabetta A., Nicholson, Andrew G., Rice, Alexandra, Devaraj, Anand, Segal, Leopoldo N., Byrne, Adam J., Maher, Toby M., Lloyd, Clare M., Molyneaux, Philip L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Thoracic Society 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874329/
https://www.ncbi.nlm.nih.gov/pubmed/32692582
http://dx.doi.org/10.1164/rccm.202002-0460OC
_version_ 1783649570579808256
author Invernizzi, Rachele
Wu, Benjamin G.
Barnett, Joseph
Ghai, Poonam
Kingston, Shaun
Hewitt, Richard J.
Feary, Johanna
Li, Yonghua
Chua, Felix
Wu, Zhe
Wells, Athol U.
George, Peter M.
Renzoni, Elisabetta A.
Nicholson, Andrew G.
Rice, Alexandra
Devaraj, Anand
Segal, Leopoldo N.
Byrne, Adam J.
Maher, Toby M.
Lloyd, Clare M.
Molyneaux, Philip L.
author_facet Invernizzi, Rachele
Wu, Benjamin G.
Barnett, Joseph
Ghai, Poonam
Kingston, Shaun
Hewitt, Richard J.
Feary, Johanna
Li, Yonghua
Chua, Felix
Wu, Zhe
Wells, Athol U.
George, Peter M.
Renzoni, Elisabetta A.
Nicholson, Andrew G.
Rice, Alexandra
Devaraj, Anand
Segal, Leopoldo N.
Byrne, Adam J.
Maher, Toby M.
Lloyd, Clare M.
Molyneaux, Philip L.
author_sort Invernizzi, Rachele
collection PubMed
description Rationale: Chronic hypersensitivity pneumonitis (CHP) is a condition that arises after repeated exposure and sensitization to inhaled antigens. The lung microbiome is increasingly implicated in respiratory disease, but, to date, no study has investigated the composition of microbial communities in the lower airways in CHP. Objectives: To characterize and compare the airway microbiome in subjects with CHP, subjects with idiopathic pulmonary fibrosis (IPF), and control subjects. Methods: We prospectively recruited individuals with a CHP diagnosis (n = 110), individuals with an IPF diagnosis (n = 45), and control subjects (n = 28). Subjects underwent BAL and bacterial DNA was isolated, quantified by quantitative PCR and the 16S ribosomal RNA gene was sequenced to characterize the bacterial communities in the lower airways. Measurements and Main Results: Distinct differences in the microbial profiles were evident in the lower airways of subjects with CHP and IPF. At the phylum level, the prevailing microbiota of both subjects with IPF and subjects with CHP included Firmicutes, Bacteroidetes, Proteobacteria, and Actinobacteria. However, in IPF, Firmicutes dominated, whereas the percentage of reads assigned to Proteobacteria in the same group was significantly lower than the percentage found in subjects with CHP. At the genus level, the Staphylococcus burden was increased in CHP, and Actinomyces and Veillonella burdens were increased in IPF. The lower airway bacterial burden in subjects with CHP was higher than that in control subjects but lower than that of those with IPF. In contrast to IPF, there was no association between bacterial burden and survival in CHP. Conclusions: The microbial profile of the lower airways in subjects with CHP is distinct from that of IPF, and, notably, the bacterial burden in individuals with CHP fails to predict survival.
format Online
Article
Text
id pubmed-7874329
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Thoracic Society
record_format MEDLINE/PubMed
spelling pubmed-78743292021-02-11 The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis Invernizzi, Rachele Wu, Benjamin G. Barnett, Joseph Ghai, Poonam Kingston, Shaun Hewitt, Richard J. Feary, Johanna Li, Yonghua Chua, Felix Wu, Zhe Wells, Athol U. George, Peter M. Renzoni, Elisabetta A. Nicholson, Andrew G. Rice, Alexandra Devaraj, Anand Segal, Leopoldo N. Byrne, Adam J. Maher, Toby M. Lloyd, Clare M. Molyneaux, Philip L. Am J Respir Crit Care Med Original Articles Rationale: Chronic hypersensitivity pneumonitis (CHP) is a condition that arises after repeated exposure and sensitization to inhaled antigens. The lung microbiome is increasingly implicated in respiratory disease, but, to date, no study has investigated the composition of microbial communities in the lower airways in CHP. Objectives: To characterize and compare the airway microbiome in subjects with CHP, subjects with idiopathic pulmonary fibrosis (IPF), and control subjects. Methods: We prospectively recruited individuals with a CHP diagnosis (n = 110), individuals with an IPF diagnosis (n = 45), and control subjects (n = 28). Subjects underwent BAL and bacterial DNA was isolated, quantified by quantitative PCR and the 16S ribosomal RNA gene was sequenced to characterize the bacterial communities in the lower airways. Measurements and Main Results: Distinct differences in the microbial profiles were evident in the lower airways of subjects with CHP and IPF. At the phylum level, the prevailing microbiota of both subjects with IPF and subjects with CHP included Firmicutes, Bacteroidetes, Proteobacteria, and Actinobacteria. However, in IPF, Firmicutes dominated, whereas the percentage of reads assigned to Proteobacteria in the same group was significantly lower than the percentage found in subjects with CHP. At the genus level, the Staphylococcus burden was increased in CHP, and Actinomyces and Veillonella burdens were increased in IPF. The lower airway bacterial burden in subjects with CHP was higher than that in control subjects but lower than that of those with IPF. In contrast to IPF, there was no association between bacterial burden and survival in CHP. Conclusions: The microbial profile of the lower airways in subjects with CHP is distinct from that of IPF, and, notably, the bacterial burden in individuals with CHP fails to predict survival. American Thoracic Society 2021-02-01 2021-02-01 /pmc/articles/PMC7874329/ /pubmed/32692582 http://dx.doi.org/10.1164/rccm.202002-0460OC Text en Copyright © 2021 by the American Thoracic Society https://creativecommons.org/licenses/by/4.0/ This article is open access and distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Original Articles
Invernizzi, Rachele
Wu, Benjamin G.
Barnett, Joseph
Ghai, Poonam
Kingston, Shaun
Hewitt, Richard J.
Feary, Johanna
Li, Yonghua
Chua, Felix
Wu, Zhe
Wells, Athol U.
George, Peter M.
Renzoni, Elisabetta A.
Nicholson, Andrew G.
Rice, Alexandra
Devaraj, Anand
Segal, Leopoldo N.
Byrne, Adam J.
Maher, Toby M.
Lloyd, Clare M.
Molyneaux, Philip L.
The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis
title The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis
title_full The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis
title_fullStr The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis
title_full_unstemmed The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis
title_short The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis
title_sort respiratory microbiome in chronic hypersensitivity pneumonitis is distinct from that of idiopathic pulmonary fibrosis
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874329/
https://www.ncbi.nlm.nih.gov/pubmed/32692582
http://dx.doi.org/10.1164/rccm.202002-0460OC
work_keys_str_mv AT invernizzirachele therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT wubenjaming therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT barnettjoseph therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT ghaipoonam therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT kingstonshaun therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT hewittrichardj therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT fearyjohanna therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT liyonghua therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT chuafelix therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT wuzhe therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT wellsatholu therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT georgepeterm therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT renzonielisabettaa therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT nicholsonandrewg therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT ricealexandra therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT devarajanand therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT segalleopoldon therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT byrneadamj therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT mahertobym therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT lloydclarem therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT molyneauxphilipl therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT invernizzirachele respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT wubenjaming respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT barnettjoseph respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT ghaipoonam respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT kingstonshaun respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT hewittrichardj respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT fearyjohanna respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT liyonghua respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT chuafelix respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT wuzhe respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT wellsatholu respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT georgepeterm respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT renzonielisabettaa respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT nicholsonandrewg respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT ricealexandra respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT devarajanand respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT segalleopoldon respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT byrneadamj respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT mahertobym respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT lloydclarem respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis
AT molyneauxphilipl respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis